|
1
|
Potente M and Mäkinen T: Vascular
heterogeneity and specialization in development and disease. Nat
Rev Mol Cell Biol. 18:477–494. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Münzel T, Camici GG, Maack C, Bonetti NR,
Fuster V and Kovacic JC: Impact of oxidative stress on the heart
and vasculature: Part 2 of a 3-part series. J Am Coll Cardiol.
70:212–229. 2017. View Article : Google Scholar
|
|
3
|
Todorova D, Simoncini S, Lacroix R,
Sabatier F and Dignat-George F: Extracellular vesicles in
angiogenesis. Circ Res. 120:1658–1673. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mathieu M, Martin-Jaular L, Lavieu G and
Théry C: Specificities of secretion and uptake of exosomes and
other extracellular vesicles for cell-to-cell communication. Nat
Cell Biol. 21:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Zhang Y, Liu Y, Dai X, Li W, Cai X,
Yin Y, Wang Q, Xue Y, Wang C, et al: Microvesicle-mediated transfer
of microRNA-150 from monocytes to endothelial cells promotes
angiogenesis. J Biol Chem. 288:23586–23596. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng B, Yin WN, Suzuki T, Zhang XH, Zhang
Y, Song LL, Jin LS, Zhan H, Zhang H, Li JS and Wen JK:
Exosome-mediated miR-155 transfer from smooth muscle cells to
endothelial cells induces endothelial injury and promotes
atherosclerosis. Mol Ther. 25:1279–1294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deregibus MC, Cantaluppi V, Calogero R, Lo
Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B and Camussi G:
Endothelial progenitor cell derived microvesicles activate an
angiogenic program in endothelial cells by a horizontal transfer of
mRNA. Blood. 110:2440–2448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gong M, Yu B, Wang J, Wang Y, Liu M, Paul
C, Millard RW, Xiao DS, Ashraf M and Xu M: Mesenchymal stem cells
release exosomes that transfer miRNAs to endothelial cells and
promote angiogenesis. Oncotarget. 8:45200–45212. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Umezu T, Tadokoro H, Azuma K, Yoshizawa S,
Ohyashiki K and Ohyashiki JH: Exosomal miR-135b shed from hypoxic
multiple myeloma cells enhances angiogenesis by targeting
factor-inhib-iting HIF-1. Blood. 124:3748–3757. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Balkom BW, de Jong OG, Smits M,
Brummelman J, den Ouden K, de Bree PM, van Eijndhoven MA, Pegtel
DM, Stoorvogel W, Würdinger T and Verhaar MC: Endothelial cells
require miR-214 to secrete exosomes that suppress senescence and
induce angiogenesis in human and mouse endothelial cells. Blood.
121:3997–4006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lombardo G, Dentelli P, Togliatto G, Rosso
A, Gili M, Gallo S, Deregibus MC, Camussi G and Brizzi MF:
Activated Stat5 trafficking via endothelial cell-derived
extracellular vesicles controls IL-3 pro-angiogenic paracrine
action. Sci Rep. 6:256892016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim YW and Byzova TV: Oxidative stress in
angiogenesis and vascular disease. Blood. 123:625–631. 2014.
View Article : Google Scholar :
|
|
13
|
Sun LL, Li WD, Lei FR and Li XQ: The
regulatory role of microRNAs in angiogenesis-related diseases. J
Cell Mol Med. 22:4568–4587. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonauer A, Carmona G, Iwasaki M, Mione M,
Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, et
al: MicroRNA-92a controls angiogenesis and functional recovery of
ischemic tissues in mice. Science. 324:1710–1713. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iaconetti C, Polimeni A, Sorrentino S,
Sabatino J, Pironti G, Esposito G, Curcio A and Indolfi C:
Inhibition of miR-92a increases endothelial proliferation and
migration in vitro as well as reduces neointimal proliferation in
vivo after vascular injury. Basic Res Cardiol. 107:2962012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hinkel R, Penzkofer D, Zühlke S, Fischer
A, Husada W, Xu QF, Baloch E, van Rooij E, Zeiher AM, Kupatt C and
Dimmeler S: Inhibition of microRNA-92a protects against
ischemia/reperfusion injury in a large-animal model. Circulation.
128:1066–1075. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Daniel JM, Penzkofer D, Teske R, Dutzmann
J, Koch A, Bielenberg W, Bonauer A, Boon RA, Fischer A, Bauersachs
J, et al: Inhibition of miR-92a improves re-endothelialization and
prevents neointima formation following vascular injury. Cardiovasc
Res. 103:564–572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bellera N, Barba I, Rodriguez-Sinovas A,
Ferret E, Asín MA, Gonzalez-Alujas MT, Pérez-Rodon J, Esteves M,
Fonseca C, Toran N, et al: Single intracoronary injection of
encapsulated antagomir-92a promotes angiogenesis and prevents
adverse infarct remodeling. J Am Heart Assoc. 3:e0009462014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Li Q, Hosen MR, Zietzer A, Flender
A, Levermann P, Schmitz T, Frühwald D, Goody P, Nickenig G, et al:
Atherosclerotic conditions promote the packaging of functional
MicroRNA-92a-3p into endothelial microvesicles. Circ Res.
124:575–587. 2019. View Article : Google Scholar
|
|
20
|
Bang C, Batkai S, Dangwal S, Gupta SK,
Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, et al:
Cardiac fibroblast-derived microRNA passenger strand-enriched
exosomes mediate cardiomyocyte hypertrophy. J Clin Invest.
124:2136–2146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li S, Chen H, Ren J, Geng Q, Song J, Lee
C, Cao C, Zhang J and Xu N: MicroRNA-223 inhibits tissue factor
expression in vascular endothelial cells. Atherosclerosis.
237:514–520. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Li S, Geng Q, Chen H, Zhang J, Cao C,
Zhang F, Song J, Liu C and Liang W: The potential inhibitory
effects of miR-19b on vulnerable plaque formation via the
suppression of STAT3 transcriptional activity. Int J Mol Med.
41:859–867. 2018.
|
|
24
|
Rabiolo A, Bignami F, Rama P and Ferrari
G: VesselJ: A new tool for semiautomatic measurement of corneal
neovascularization. Invest Ophthalmol Vis Sci. 56:8199–8206. 2015.
View Article : Google Scholar
|
|
25
|
van Balkom BW, Eisele AS, Pegtel DM,
Bervoets S and Verhaar MC: Quantitative and qualitative analysis of
small RNAs in human endothelial cells and exosomes provides
insights into localized RNA processing, degradation and sorting. J
Extracell Vesicles. 4:267602015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rehmsmeier M, Steffen P, Hochsmann M and
Giegerich R: Fast and effective prediction of microRNA/target
duplexes. RNA. 10:1507–1517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eisenreich A and Rauch U: Regulation and
differential role of the tissue factor isoforms in cardiovascular
biology. Trends Cardiovasc Med. 20:199–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Raposo G and Stahl PD: Extracellular
vesicles: A new communication paradigm? Nat Rev Mol Cell Biol.
20:509–510. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Yang F, Zhang T, Wang W, Xi W, Li
Y, Zhang D, Huo Y, Zhang J, Yang A and Wang T: MiR-9 promotes
tumorigenesis and angiogenesis and is activated by MYC and OCT4 in
human glioma. J Exp Clin Cancer Res. 38:992019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhuang G, Wu X, Jiang Z, Kasman I, Yao J,
Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D and Ferrara N:
Tumour-secreted miR-9 promotes endothelial cell migration and
angiogenesis by activating the JAK-STAT pathway. EMBO J.
31:3513–3523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Madelaine R, Sloan SA, Huber N, Notwell
JH, Leung LC, Skariah G, Halluin C, Paşca SP, Bejerano G, Krasnow
MA, et al: MicroRNA-9 couples brain neurogenesis and angiogenesis.
. Cell Rep. 20:1533–1542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang H, Qi M, Li S, Qi T, Mei H, Huang K,
Zheng L and Tong Q: MicroRNA-9 targets matrix metalloproteinase 14
to inhibit invasion, metastasis, and angiogenesis of neuroblastoma
cells. Mol Cancer Ther. 11:1454–1466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shyu KG, Wang BW, Pan CM, Fang WJ and Lin
CM: Hyperbaric oxygen boosts long noncoding RNA MALAT1 exosome
secretion to suppress microRNA-92a expression in therapeutic
angiogenesis. Int J Cardiol. 274:271–278. 2019. View Article : Google Scholar
|
|
34
|
Eisenreich A, Bolbrinker J and Leppert U:
Tissue factor: A conventional or alternative target in cancer
therapy. Clin Chem. 62:563–570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Versteeg HH, Schaffner F, Kerver M,
Petersen HH, Ahamed J, Felding-Habermann B, Takada Y, Mueller BM
and Ruf W: Inhibition of tissue factor signaling suppresses tumor
growth. Blood. 111:190–199. 2008. View Article : Google Scholar
|
|
36
|
van den Berg YW, van den Hengel LG, Myers
HR, Ayachi O, Jordanova E, Ruf W, Spek CA, Reitsma PH, Bogdanov VY
and Versteeg HH: Alternatively spliced tissue factor induces
angiogenesis through integrin ligation. Proc Natl Acad Sci USA.
106:19497–19502. 2009. View Article : Google Scholar : PubMed/NCBI
|
